VSTM
Price:
$10.6
Market Cap:
$641.71M
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylate MEK. The company also engages in developing RAMP 201, an adaptive two-part multicenter, parallel cohort, randomized open label trial to evaluate the efficacy and safety of VS-6766 and in combination with defactinib, an oral small molecule inhibitor of focal adhesion kinase (FAK) in patients with recurrent low grade serous ovarian cancer; and RAMP 20...[Read more]
Industry
Biotechnology
IPO Date
2012-01-27
Stock Exchange
NASDAQ
Ticker
VSTM
According to Verastem, Inc.’s latest financial reports and current stock price. The company's current ROE is -9587.28%. This represents a change of -16230.20% compared to the average of 59.44% of the last 4 quarters.
The mean historical ROE of Verastem, Inc. over the last ten years is -235.86%. The current -9587.28% ROE has changed 3.96% with respect to the historical average. Over the past ten years (40 quarters), VSTM's ROE was at its highest in in the December 2024 quarter at 223.41%. The ROE was at its lowest in in the December 2019 quarter at -540.48%.
Average
-235.86%
Median
-70.03%
Minimum
-2079.86%
Maximum
452.14%
Discovering the peaks and valleys of Verastem, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.47%
Maximum Annual ROE = 452.14%
Minimum Annual Increase = -396.92%
Minimum Annual ROE = -2079.86%
| Year | ROE | Change |
|---|---|---|
| 2024 | 452.14% | -396.92% |
| 2023 | -152.28% | -2.28% |
| 2022 | -155.83% | 91.63% |
| 2021 | -81.32% | 38.41% |
| 2020 | -58.75% | -97.18% |
| 2019 | -2079.86% | 3.47% |
| 2018 | -58.27% | -50.42% |
| 2017 | -117.54% | 133.20% |
| 2016 | -50.40% | -10.74% |
| 2015 | -56.47% | -6.07% |
The current ROE of Verastem, Inc. (VSTM) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
48.01%
5-year avg
0.79%
10-year avg
-235.86%
Verastem, Inc.’s ROE is less than REGENXBIO Inc. (-78.29%), less than Absci Corporation (-60.21%), less than MoonLake Immunotherapeutics (-41.61%), greater than KalVista Pharmaceuticals, Inc. (-195.62%), less than Prothena Corporation plc (-72.66%), less than Ventyx Biosciences, Inc. (-48.11%), less than Olema Pharmaceuticals, Inc. (-41.51%), less than 4D Molecular Therapeutics, Inc. (-47.27%), greater than Gossamer Bio, Inc. (-1774.72%), less than Corvus Pharmaceuticals, Inc. (-25.78%),
| Company | ROE | Market cap |
|---|---|---|
| -78.29% | $657.04M | |
| -60.21% | $560.88M | |
| -41.61% | $955.18M | |
| -195.62% | $828.96M | |
| -72.66% | $600.74M | |
| -48.11% | $570.87M | |
| -41.51% | $1.90B | |
| -47.27% | $522.60M | |
| -1774.72% | $753.86M | |
| -25.78% | $657.64M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Verastem, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Verastem, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Verastem, Inc.'s ROE?
How is the ROE calculated for Verastem, Inc. (VSTM)?
What is the highest ROE for Verastem, Inc. (VSTM)?
What is the 3-year average ROE for Verastem, Inc. (VSTM)?
What is the 5-year average ROE for Verastem, Inc. (VSTM)?
How does the current ROE for Verastem, Inc. (VSTM) compare to its historical average?